Nephrogen
YC S20Curative genetic medicines for kidney diseases
New York, NY, USAFounded 20225 employeeswww.nephrogenbiotech.com
Team
5
Founded
2022
About
Nephrogen is a Stanford biotech spin-out developing curative genetic medicines for kidney and pancreatic diseases. Kidney disease alone affects 1 in 7 Americans, and neither indication has any approved gene-based therapies. Nephrogen's underlying platform combines AI and high-throughput screening to engineer safer, more efficient, and less expensive gene delivery vehicles for reaching the kidney and pancreas, and has attracted non-dilutive funding from seven major pharmaceutical companies including Merck KGaA, Novartis, and Bristol Myers Squibb.
Tags
Gene Therapy CRISPR Biotech Healthcare
No open roles at this time.
Similar Healthcare startups
CoreCare
Helping healthcare providers reduce administrative costs using AI
B2BWorkflow AutomationEnterprise Software
Open Jobs —
Team 11
Founded 2020
Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
TherapeuticsPsychedelicsMental Health
Open Jobs —
Team 15
Founded 2020
Kingdom
Natural functional ingredients that actually work
Health & WellnessFood Tech
Open Jobs —
Team 18
Founded 2020
Liyfe
Digital Nurse to Automate Symptom Assessment and Risk…
SaaSDigital Health
Open Jobs —
Team 2
Founded 2020